sn-Glycero-3-phosphoethanolamine (BioCAD00000017801)

feces brain liver placenta prostate

Metabolite Card

Formula: C5H14NO6P (215.0559)
SMILES: NCCOP(O)(=O)OCC(O)CO

Synonyms [en]

sn-Glycero-3-phosphoethanolamine; glycerylphosphorylethanolamine; glycerophosphoethanolamine; sn-Glycerol-3-phosphoethanolamine; Glycerol 3-phosphoethanolamine; Glyceryl-3-phosphorylethanolamine

Reviewed

Last reviewed on 2024-06-28.

Cite this Page

sn-Glycero-3-phosphoethanolamine. 数据之源,洞见之始. SMRUCC genomics institute, a synthetic life researcher from China. https://biocad_registry.innovation.ac.cn/s/(-)-arctiin (retrieved 2026-01-03) (CAD Registry RN: BioCAD00000017801). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

Note

Glycerylphosphorylethanolamine is a membrane breakdown product resulting from the cleavage of the lipid group from glycerophosphoethanlomine fatty acids (i.e. phosphatidylethanolamine). It acts as a growth stimulant for hepatocytes.

Entity Information

DBLinks

Other DBLinks
  • CAS Registry Number: 1190-00-7
  • CAS Registry Number: 33049-08-0
  • CAS Registry Number: 59734-15-5
  • PubChem: 123874
  • PubChem: 444183
  • PubChem: 5459861
  • ChEBI: ChEBI:134287
  • ChEBI: ChEBI:16929
  • ChEBI: ChEBI:52330
  • HMDB: HMDB0000114
  • HMDB: HMDB00114
  • HMDB: HMDB59660
  • KEGG: C01233
  • NCBI MeSH: glycerophosphoethanolamine
  • DrugBank: DB03484
  • RefMet: RM0157553
  • MoNA: MoNA015850
  • Metlin: METLIN_5151
  • Metlin: METLIN_96256
  • Coconut NaturalProduct: CNP0094712.0

Class / Ontology

Metabolic Network
ID EC Number Name
KEGG:R01470 3.1.4.2 sn-glycero-3-phosphoethanolamine glycerophosphohydrolase
KEGG:R03415 3.3.2.2 1-(1-alkenyl)-sn-glycero-3-phosphoethanolamine aldehydohydrolase
KEGG:R03416 3.1.1.5 1-acyl-sn-glycero-3-phosphoethanolamine aldehydohydrolase
KEGG:R03417 3.1.1.5 L-2-lysophosphatidylethanolamine aldehydohydrolase
View More
Organism Source

Taxonomy Source

Pathway Synthetic

pathway id name
WikiPathways:WP3604 Biochemical pathways: part I
View All Pathways